Viewing Study NCT05756569


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2025-12-25 @ 8:25 PM
Study NCT ID: NCT05756569
Status: RECRUITING
Last Update Posted: 2025-07-28
First Post: 2023-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module